MDPI and ACS Style
Zubiaur, P.; Matas, M.; Martín-Vílchez, S.; Soria-Chacartegui, P.; Villapalos-García, G.; Figueiredo-Tor, L.; Calleja, S.; Navares-Gómez, M.; de Miguel, A.; Novalbos, J.;
et al. Polymorphism of Drug Transporters, Rather Than Metabolizing Enzymes, Conditions the Pharmacokinetics of Rasagiline. Pharmaceutics 2022, 14, 2001.
https://doi.org/10.3390/pharmaceutics14102001
AMA Style
Zubiaur P, Matas M, Martín-Vílchez S, Soria-Chacartegui P, Villapalos-García G, Figueiredo-Tor L, Calleja S, Navares-Gómez M, de Miguel A, Novalbos J,
et al. Polymorphism of Drug Transporters, Rather Than Metabolizing Enzymes, Conditions the Pharmacokinetics of Rasagiline. Pharmaceutics. 2022; 14(10):2001.
https://doi.org/10.3390/pharmaceutics14102001
Chicago/Turabian Style
Zubiaur, Pablo, Miriam Matas, Samuel Martín-Vílchez, Paula Soria-Chacartegui, Gonzalo Villapalos-García, Laura Figueiredo-Tor, Sofía Calleja, Marcos Navares-Gómez, Alejandro de Miguel, Jesús Novalbos,
and et al. 2022. "Polymorphism of Drug Transporters, Rather Than Metabolizing Enzymes, Conditions the Pharmacokinetics of Rasagiline" Pharmaceutics 14, no. 10: 2001.
https://doi.org/10.3390/pharmaceutics14102001